The balance sheet appears well-capitalized with equity-to-assets improving from 0.10 to 0.14 and total assets reaching $2.0B, yet ROE simultaneously halved from 6.4% to 3.8% and the investment securities portfolio swung from $52.1M (2026Q1) to $1.7B (2026Q3), raising questions about capital deployment efficiency and portfolio classification stability.
Bank7 Corp. (BSVN) balance sheet — 10-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Cash & Short Term Investments | 1.15B | 255.09M | 273.14M | 338.41M | 287.75M | 283.4M | 170.31M | 147.28M | 159.85M | 130.22M | 103.67M |
| Cash & Due from Banks | 277.18M | 244.63M | 240.91M | 198.72M | 114.59M | 198.6M | 170.31M | 147.28M | 159.85M | 130.22M | 103.67M |
| Short Term Investments | 47.54M | 10.46M | 32.22M | 139.69M | 173.16M | 84.81M | 0 | 0 | 0 | 0 | 0 |
| Total Investments | 1.66B | 65.64M | 1.41B | 1.48B | 1.43B | 1.1B | 828.47M | 701.59M | 593.64M | 556.78M | 496.81M |
| Investments Growth % | -282.81% | -95.35% | -4.71% | 3.69% | 29.47% | 33.33% | 18.08% | 18.18% | 6.62% | 12.07% | - |
| Long-Term Investments | 1.67B | 55.18M | 1.38B | 1.34B | 1.26B | 1.02B | 828.47M | 701.59M | 593.64M | 556.78M | 496.81M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 16.44M | 10.52M | 7.15M | 6.12M | 7.16M | 4.68M | 4.27M |
| Goodwill & Intangibles | 11.87M | 11.96M | 9.34M | 9.49M | 9.94M | 10.12M | 1.58M | 1.79M | 2M | 2.2M | 2.41M |
| Goodwill | 11.21M | 11.21M | 8.46M | 8.46M | 8.6M | 8.48M | 1.01M | 1.01M | 1.01M | 1.01M | 1.01M |
| Intangible Assets | 658K | 752K | 878K | 1.03M | 1.34M | 1.64M | 572K | 778K | 984K | 1.19M | 1.4M |
| PP&E (Net) | 27.13M | 21.88M | 18.14M | 14.94M | 13.11M | 17.26M | 9.15M | 9.62M | 7.75M | 9.6M | 6.51M |
| Other Assets | 25.7M | -55.18M | 58.45M | 65.68M | 0 | 9.49M | 0 | 0 | 110K | 100K | 103.44K |
| Total Current Assets | 327.39M | 298.65M | 273.14M | 338.41M | 304.19M | 293.93M | 177.47M | 153.39M | 167.01M | 134.91M | 107.94M |
| Total Non-Current Assets | 1.68B | 33.84M | 1.47B | 1.43B | 1.28B | 1.06B | 839.2M | 713M | 603.5M | 568.69M | 505.84M |
| Total Assets | 2.01B | 1.96B | 1.74B | 1.77B | 1.58B | 1.35B | 1.02B | 866.39M | 770.51M | 703.59M | 613.77M |
| Asset Growth % | 32.16% | 12.87% | -1.8% | 11.84% | 17.3% | 32.84% | 17.35% | 12.44% | 9.51% | 14.63% | - |
| Return on Assets (ROA) | 2.11% | 2.33% | 2.6% | 1.69% | 2.02% | 1.96% | 2.05% | 1% | 3.39% | 3.61% | 2.74% |
| Accounts Payable | 0 | 0 | 0 | 0 | 9.71M | 5.67M | 3.84M | 8.43M | 4.23M | 2.99M | 2.68M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.6M | 6.4M |
| Net Debt | -277.18M | -244.63M | -240.91M | -198.72M | -114.59M | -198.6M | -170.31M | -147.28M | -159.85M | -124.62M | -97.27M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.6M | 6.4M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 12.06M | 1.71B | 11.12M | 9.65M | -1.05M | 0 | 0 | 8.43M | 4.23M | 0 | 0 |
| Total Current Liabilities | 1.72B | 594K | 1.52B | 1.59B | 1.44B | 1.22B | 909.35M | 757.84M | 677.82M | 628.82M | 552.23M |
| Total Non-Current Liabilities | 12.06M | 1.71B | 11.12M | 9.65M | -1.05M | 0 | 0 | 8.43M | 4.23M | 5.6M | 6.4M |
| Total Liabilities | 1.73B | 1.71B | 1.53B | 1.6B | 1.44B | 1.22B | 909.35M | 766.27M | 682.04M | 634.42M | 558.63M |
| Total Equity | 273.73M | 251M | 213.21M | 170.33M | 144.1M | 127.41M | 107.32M | 100.13M | 88.47M | 69.18M | 55.14M |
| Equity Growth % | 63.03% | 17.72% | 25.18% | 18.2% | 13.1% | 18.72% | 7.18% | 13.18% | 27.89% | 25.46% | - |
| Equity / Assets (Capital Ratio) | 13.64% | 12.78% | 12.25% | 9.61% | 9.1% | 9.43% | 10.56% | 11.56% | 11.48% | 9.83% | 8.98% |
| Return on Equity (ROE) | 15.74% | 18.56% | 23.83% | 17.99% | 21.83% | 19.73% | 18.57% | 8.7% | 31.72% | 38.27% | 30.5% |
| Book Value per Share | 28.39 | 26.22 | 22.57 | 18.39 | 15.65 | 14.01 | 11.44 | 9.87 | 10.74 | 6.79 | 5.41 |
| Tangible BV per Share | 27.16 | 24.97 | 21.58 | 17.36 | 14.57 | 12.90 | 11.27 | 9.69 | 10.50 | 6.57 | 5.18 |
| Common Stock | 95K | 95K | 94K | 92K | 91K | 91K | 90K | 101K | 102K | 73K | 72.88K |
| Additional Paid-in Capital | 104.58M | 103.74M | 101.81M | 97.42M | 95.26M | 94.02M | 93.16M | 92.39M | 80.28M | 6.99M | 6.99M |
| Retained Earnings | 172.26M | 149.71M | 116.28M | 78.96M | 58.05M | 33.15M | 14.07M | 7.61M | 8.09M | 62.12M | 48.08M |
| Accumulated OCI | -3.21M | -2.55M | -4.97M | -6.14M | -9.3M | 144K | 0 | 0 | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying BSVN stock.
As of 2025, Bank7 Corp. (BSVN) had total assets of $1.96B including $298.7M in current assets.
Bank7 Corp. (BSVN) carries total debt of $0.0M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Bank7 Corp. (BSVN) has total shareholders' equity (book value) of $251.0M ($26.22 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Bank7 Corp. (BSVN) reported a current ratio of 502.78x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
ROE Erosion Despite Equity Buildup
Metrics are mathematically derived from official filings.
Capital Ratio Expansion Masking Returns Erosion
According to recent SEC filings, Bank7's equity-to-assets ratio climbed from 0.10 in 2024Q1 to 0.14 in 2026Q3—a 40% improvement—yet ROE simultaneously fell from 6.4% to 3.8%, suggesting the bank is accumulating capital faster than it can deploy it profitably.
The steady equity build from $180.4M to $273.7M over ten quarters appears to reflect retained earnings accumulation with minimal capital return, consistent with negligible share repurchases and rising dividend payments. While the 14% equity/assets ratio provides a meaningful buffer against credit losses, the inverse relationship between rising capital and falling ROE suggests the balance sheet may be becoming over-capitalized relative to its earning-asset base. Investors should monitor whether management articulates a clearer capital deployment framework, as idle capital at a sub-4% ROE environment may signal strategic indecision rather than prudential conservatism.
Securities Portfolio Volatility Raises Structural Questions
As reported in financial statements, Bank7's investment securities portfolio swung from $1.6B in 2025Q3 to just $52.1M in 2026Q1 before rebounding to $1.7B in 2026Q3—a pattern suggesting either significant portfolio restructuring or classification shifts that warrants careful analyst scrutiny.
The dramatic reduction and subsequent re-emergence of the securities portfolio across these three quarters is among the most unusual patterns in the ten-quarter dataset, as the balance sheet simultaneously shows stable total assets near $1.9-2.0B. This oscillation, when combined with the cash position ranging between $218M and $277M, suggests the bank may have engaged in temporary repositioning of its earning-asset mix rather than a sustained strategic shift. The lack of corresponding swings in total assets implies offsetting movements elsewhere on the balance sheet that the summary data does not fully illuminate, and investors should seek additional disclosure to understand what drove this allocation change.
Balance Sheet Growth Decoupled from Earnings Power
Based on EDBL's reported figures, Bank7's total assets grew approximately 11% from $1.8B in 2024Q1 to $2.0B in 2026Q3, yet net interest income declined from $22.0M to $22.3M and NIM compressed from 1.2% to 1.1%, indicating the incremental balance sheet is generating diminishing marginal returns.
The asset growth appears to have come disproportionately from funding-side expansion rather than loan deployment, as the consistent absence of the loan-to-deposit ratio metric limits visibility into whether the loan book is keeping pace with deposit growth. The equity base expanded 52% over the period while NII barely moved, which mechanically depresses ROE from 6.4% to 3.8% and suggests the bank's earning-asset yield is not scaling with its expanding capital base. This decoupling of balance sheet size from earnings power, if it persists, would represent a meaningful challenge to the franchise's long-term value creation trajectory.
NIM Compression Signals Structural Margin Headwinds
According to recent SEC filings, Bank7's net interest margin drifted from a peak of 1.3% in 2024Q2 to 1.1% by 2026Q3, a 20 basis point compression that coincided with an efficiency ratio deterioration from 37.5% to 41.7%, suggesting both asset and liability repricing pressures are converging unfavorably.
The NIM compression from 1.3% to 1.1% appears to reflect a structural repricing dynamic where the bank's loan and securities yields are adjusting more slowly than its cost of deposits—a pattern consistent with a growing and potentially stickier funding base. With efficiency ratio worsening simultaneously, the bank faces a dual squeeze that may constrain operating leverage even if the loan book continues growing. Given the minimal provisioning observed across the period, there may be limited cost relief from credit normalization, meaning NIM trajectory will likely be the primary driver of forward earnings power.
Capital Efficiency Paradox Defies Simple Narrative
The most counterintuitive balance sheet dynamic at Bank7 is that equity grew 52% and the equity-to-assets ratio improved 40% over ten quarters, yet ROE halved from 6.4% to 3.8%—suggesting the capital accumulation itself may be the mechanism destroying per-share returns rather than a sign of strength.
Conventional analysis would celebrate the 14% equity/assets ratio as a fortress indicator, but the concurrent ROE compression and NIM decline suggest the bank may be hoarding capital without an identifiable deployment pathway—a pattern more consistent with strategic uncertainty than prudent risk management. The single $700K provision in 2025Q3, against nearly $274M of equity, represents a provision-to-equity ratio of roughly 0.25%, which while indicative of a clean credit book also raises questions about whether reserve levels are calibrated to a normalizing rather than benign credit environment. If credit costs do rise from near-zero levels while NIM continues compressing, the already-deteriorating returns on equity could face compounding pressure from both sides, potentially triggering a reassessment of the premium the market may assign to this capital position.